Solventum Corporation (NYSE:SOLV) Receives $84.89 Average PT from Brokerages

Solventum Corporation (NYSE:SOLV) has received a consensus rating of “Hold” from the twelve brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $85.3333.

SOLV has been the subject of several research reports. Piper Sandler increased their price objective on Solventum from $94.00 to $98.00 and gave the company an “overweight” rating in a research report on Friday. Zacks Research upgraded shares of Solventum from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 15th. Wall Street Zen lowered shares of Solventum from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, September 9th. Weiss Ratings restated a “hold (c)” rating on shares of Solventum in a report on Thursday, October 30th. Finally, Jefferies Financial Group assumed coverage on shares of Solventum in a research report on Thursday, September 11th. They set a “hold” rating and a $80.00 price objective for the company.

Institutional Trading of Solventum

A number of hedge funds have recently modified their holdings of the company. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of Solventum by 0.7% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 19,778 shares of the company’s stock valued at $1,500,000 after purchasing an additional 140 shares during the period. Tradition Wealth Management LLC boosted its stake in Solventum by 1.6% during the first quarter. Tradition Wealth Management LLC now owns 8,830 shares of the company’s stock worth $671,000 after buying an additional 143 shares in the last quarter. CHICAGO TRUST Co NA boosted its stake in Solventum by 3.0% during the third quarter. CHICAGO TRUST Co NA now owns 5,188 shares of the company’s stock worth $379,000 after buying an additional 150 shares in the last quarter. Applied Finance Capital Management LLC increased its holdings in Solventum by 3.8% in the 2nd quarter. Applied Finance Capital Management LLC now owns 4,428 shares of the company’s stock valued at $336,000 after buying an additional 162 shares during the period. Finally, Deseret Mutual Benefit Administrators raised its stake in shares of Solventum by 78.7% in the 3rd quarter. Deseret Mutual Benefit Administrators now owns 370 shares of the company’s stock valued at $27,000 after buying an additional 163 shares in the last quarter.

Solventum Trading Up 7.8%

Solventum stock opened at $71.48 on Thursday. Solventum has a 52 week low of $60.70 and a 52 week high of $85.92. The company has a debt-to-equity ratio of 2.14, a quick ratio of 0.86 and a current ratio of 1.22. The firm has a market capitalization of $12.39 billion, a PE ratio of 8.24, a PEG ratio of 2.90 and a beta of 0.48. The business’s 50-day simple moving average is $71.97 and its 200-day simple moving average is $72.44.

Solventum (NYSE:SOLV) last released its earnings results on Thursday, November 6th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.43 by $0.07. The firm had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.05 billion. Solventum had a return on equity of 31.62% and a net margin of 18.13%.The company’s revenue was up .7% on a year-over-year basis. During the same quarter last year, the firm posted $1.64 EPS. Solventum has set its FY 2025 guidance at 5.980-6.080 EPS. Equities research analysts forecast that Solventum will post 6.58 earnings per share for the current year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.